scholarly journals An outbreak of Coxsackievirus A6 infection in adults of a collective unit, China, 2019

2020 ◽  
Author(s):  
Yumeng Gao ◽  
Guangyuan Ma ◽  
Yong Xiao ◽  
Qun Cai ◽  
Yujun Chen ◽  
...  

Abstract Background: Outbreaks/epidemic caused by Coxsackievirus A6 have been reported continuously since 2008. However, outbreaks caused by Coxsackievirus A6 infection in adults of a collective unit have not been reported.Methods: The nasopharyngeal swab specimens were collected to extract the total nucleic acid (DNA/RNA). The pathogen was determined using nucleic acid detection kits for 22 respiratory pathogens. The VP1 gene of this pathogen was amplified and sequenced. Sequence alignment and analysis were performed using Bioedit. The gene phylogenetic tree was constructed with MEGA software.Results: The factory emerged patients in succession from the February 14 and reached the peak on the 18th. The main symptoms were rash, ocular conjunctival hemorrhage, fever and sore throat. A total of 19 workers had symptoms in this factory up to March 31, 2019, giving an attack rate of 8.26%. The laboratory results showed that Coxsackievirus A6 was the main pathogen causing this outbreak. The risk of taking a bath in the bathroom was 7.37 times higher than that of not taking a bath (95% CI: 1.67-32.79).Conclusions: This manuscript further enriched the infection-related information of CVA6, which was helpful to better identify and deal with the epidemic in the future.

2019 ◽  
Author(s):  
Yumeng Gao ◽  
Guangyuan Ma ◽  
Yong Xiao ◽  
Qun Cai ◽  
Yujun Chen ◽  
...  

Abstract Background: Outbreaks/epidemic caused by Coxsackievirus A6 have been reported continuously since 2008. However, outbreaks caused by Coxsackievirus A6 infection in adults of a collective unit have not been reported. Methods: The nasopharyngeal swab specimens were collected to extract the total nucleic acid (DNA/RNA). The pathogen was determined using 22 respiratory pathogen nucleic acid detection kits. The VP1 gene of this pathogen was amplified and sequenced. Sequence alignment and analysis were performed using Bioedit. The gene phylogenetic tree was constructed with MEGA software. Results: The factory emerged patients in succession from the February 14 and reached the peak on the 18th. The main symptoms were rash, ocular conjunctival hemorrhage, fever and sore throat. A total of 19 workers had symptoms in this factory up to March 31, 2019, giving an attack rate of 8.26%. The laboratory results showed that Coxsackievirus A6 was the enterovirus type causing this outbreak. The risk of illness was 7.37 times higher taking bath in bathroom than that of not taking bath (95% CI 1.67, 32.79). Conclusions: Epidemiologic and molecular data indicated Coxsackievirus A6 as the etiology of this outbreak of adults in a collective unit, a risk factor for the spread was taking bath in the bathroom of the factory.


2020 ◽  
Author(s):  
shasha zhang

Abstract this paper introduces a method for simultaneous detection of 2019 novel coronavirus(2019-nCoV) and influenza virus by dual fluorescent RT-PCR, providing some references for the current clinical first-line practice against the epidemic. More than 1500 samples of nasopharyngeal swabs, sputum and anal swabs were collected. Nucleic acid detection kits from two manufacturers of novel coronavirus and type A/B influenza virus were selected for the detection. Carboxyfluorescein (FAM) and green fluorescent protein (VIC) labeled probes were used to achieve simultaneous detection of the four gene targets using a double fluorescent RT-PCR reaction system. According to the analysis for the results of nucleic acid detection of existing samples, there is no cross infection between 2019 novel coronavirus and type A/B influenza virus. The Ct value of novel coronavirus nucleic acid in anal swab>Ct value of sputum > Ct value of nasopharyngeal swab in the same patient. Conclusion: A method for rapid and simultaneous detection of novel coronavirus and influenza virus by dual fluorescent RT-PCR was established to improve the detection efficiency and reduce the cost, which could be used for rapid and emergent detection of 2019 novel coronavirus and type A/B influenza virus.


2021 ◽  
Vol 4 ◽  
pp. 2
Author(s):  
Jaya Kaushik ◽  
Vikas Marwah ◽  
Ankita Singh ◽  
Y. V. K. Chaitanya ◽  
Rajeev Mohan Gupta ◽  
...  

Objectives: The purpose of the study was to detect the presence of viral ribonucleic acid of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in conjunctival swab along with nasopharyngeal swab specimens of Coronavirus disease 2019 (COVID-19) patients. Material and Methods: Thirty COVID-19 patients with at least one sample positive for real-time reverse transcription-polymerase chain reaction for SARS-CoV-2 in nasopharyngeal swab with the presence or absence of ocular manifestations were included in the study. The conjunctival swab along with nasopharyngeal swab of each patient was collected and sent to microbiology lab for evaluation and analysis of viral nucleic acid to assess the viral load. Results: Out of 30 patients, 21 patients (70%) were males and the remaining nine patients (30%) were females. Mean age of the patients in the study was 44.80 ± 15.37 years. One patient had conjunctivitis as ocular manifestation. Two (6.7%) out of 30 patients were positive for RT-PCR SARS-CoV-2 in the conjunctival swab. There was no statistical correlation between nasopharyngeal swab and conjunctival swab positivity using Pearson’s correlation coefficient (r) = 0.010; P = 0.995 (>0.05). Conclusion: The results of the study revealed that SARS-CoV-2 can also be detected in conjunctival swabs of confirmed cases of COVID-19 patients. Although, in comparison to nasopharyngeal and throat swabs the rate of detection of SARS-CoV-2 in conjunctival swabs is relatively less, still diligent care and precautions should be practiced during the ophthalmic evaluation of COVID-19 patients.


2020 ◽  
Author(s):  
Alan Wolfe ◽  
David Baunoch ◽  
Dakun Wang ◽  
Ryan Gnewuch ◽  
Xinhua Zhao ◽  
...  

AbstractBackgroundElderly SARS-CoV-2 patients are associated with higher hospitalization and mortality. Co-infection is critical in the severity of respiratory diseases. It is largely understudied for SARS-CoV-2.MethodsBetween March 24th and April 27th, 2020, nasopharyngeal and oropharyngeal swabs from 3,348 patients from nursing homes and assisted living facilities in 22 states in the US were tested by Capstone Healthcare for SARS-CoV-2, 24 other respiratory viruses, and 8 respiratory bacteria. Total nucleic acid was extracted with MagMAX™ Viral/Pathogen Ultra nucleic acid isolation kit. SARS-Co-V-2 was detected with the CDC 2019-novel coronavirus (2019-nCoV) diagnostic panel. Total nucleic acid was pre-amplified before analysis for other respiratory pathogens with Taqman OpenArray™ Respiratory Tract Microbiota Plate.ResultsPatients’ mean age was 76.9 years. SARS-CoV-2 was detected in 1,413 patients (42.2%). Among them, 1,082 (76.6%) and 737 (43.7%) patients were detected with at least one bacterium or another virus, respectively. SARS-CoV-2-positive patients were more likely to have bacterial co-occurrences (76.6%) than SARS-CoV-2-negative patients (70.0%) (p<0.0001). The most common co-occurring bacteria were Staphylococcus aureus and Klebsiella pneumonia, detected in 55.8% and 40.1% SARS-CoV-2-positive patients, respectively. Staphylococcus aureus was associated with SARS-CoV-2, with higher detection rates in SARS-CoV-2-positive patients (55.8%) than SARS-CoV-2-negative patients (46.2%) (p<0.0001). Human herpes virus 6 (HHV6) also was common and associated with SARS-CoV-2, with higher detection rates in SARS-CoV-2-positive patients (26.6%) than SARS-CoV-2-negative patients (19.1%) (p<0.0001).ConclusionsSARS-CoV-2-positive patients are more likely to be positive for certain respiratory bacteria and viruses. This observation may help explain high hospitalization and mortality rates in older patients.


Author(s):  
Alain Laurent ◽  
Arnaud Burr ◽  
Thibault Martin ◽  
Frédéric Lasnet ◽  
Sébastien Hauser ◽  
...  

Viruses ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 615
Author(s):  
Allen Wing-Ho Chu ◽  
Cyril Chik-Yan Yip ◽  
Wan-Mui Chan ◽  
Anthony Chin-Ki Ng ◽  
Dream Lok-Sze Chan ◽  
...  

SARS-CoV-2 RT-PCR with pooled specimens has been implemented during the COVID-19 pandemic as a cost- and manpower-saving strategy for large-scale testing. However, there is a paucity of data on the efficiency of different nucleic acid extraction platforms on pooled specimens. This study compared a novel automated high-throughput liquid-based RNA extraction (LRE) platform (PHASIFYTM) with a widely used magnetic bead-based total nucleic acid extraction (MBTE) platform (NucliSENS® easyMAG®). A total of 60 pools of nasopharyngeal swab and 60 pools of posterior oropharyngeal saliva specimens, each consisting of 1 SARS-CoV-2 positive and 9 SARS-CoV-2 negative specimens, were included for the comparison. Real-time RT-PCR targeting the SARS-CoV-2 RdRp/Hel gene was performed, and GAPDH RT-PCR was used to detect RT-PCR inhibitors. No significant differences were observed in the Ct values and overall RT-PCR positive rates between LRE and MBTE platforms (92.5% (111/120] vs 90% (108/120]), but there was a slightly higher positive rate for LRE (88.3% (53/60]) than MBTE (81.7% (49/60]) among pooled saliva. The automated LRE method is comparable to a standard MBTE method for the detection of SAR-CoV-2 in pooled specimens, providing a suitable alternative automated extraction platform. Furthermore, LRE may be better suited for pooled saliva specimens due to more efficient removal of RT-PCR inhibitors.


Sign in / Sign up

Export Citation Format

Share Document